Scientists

Scientists

For science to make the news in a rigorous and attractive way, good sources are needed. Because access to scientific knowledge is a citizen's right.

¿Qué me ofrece?

Help science make headlines with rigour and context. We’ll ask you for feedback on current events in your field and you can participate in the briefings we’ll organise. Need to prepare for an interview? Use our resources on science communication.

Icono
Cómo trabajamos

We’re on the lookout for controversial information about science and we will contact you for your analysis in your area. Do you want to be part of our sources? Contact us. We will not pass your contact details on to anyone else. You can find out more about how we work here.   

Título qué me ofrece
What we offer you
Título cómo trabajamos
How we work

Reactions to the announcement of the creation of a "green energy corridor" linking the Iberian Peninsula to Europe

On Thursday, president Pedro Sánchez announced an agreement with France and Portugal to create the "green energy corridor", which will connect Spain, Portugal and France to the European Union's energy network. According to the government, the corridor envisages the creation of a maritime gas pipeline connecting Barcelona with Marseille, which will be used to transport natural gas, hydrogen and other gases.  

0

Reaction: mice that confront the aggressor develop greater resilience than those that flee

A study in mice published in the journal Nature has analysed the different responses to aggression and the consequences for subsequent behaviour. In general, animals that confronted the aggressor developed greater resilience than those that fled or avoided the aggressor, and the gain was greater as brain circuits associated with dopamine were activated.

0

Reaction to study claiming that life expectancy recovered in 2021 in some countries, including Spain

Research published in Nature Human Behaviour analyses changes in life expectancy since the advent of covid-19. Its findings show that some countries in western Europe, including Spain, regained some of their lost life expectancy, and others returned to 2019 levels. On the other hand, losses continued in Eastern Europe and the United States.

0

Reactions: EMA gives green light to new dengue vaccine

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting marketing authorisation for the tetravalent dengue vaccine (live, attenuated) Takeda. The vaccine is intended to prevent disease caused by dengue virus serotypes 1, 2, 3 and 4 in people aged four years and older. Although an approved vaccine already exists, according to the EMA, this quadrivalent vaccine shows increased protection in children and people over 45 years of age.

0